Advertisement

Index by author

November 01, 1989; Volume 17,Issue 6

A

  1. Argenbright, L S

    1. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
      G L Kedderis, L S Argenbright, J S Walsh, J L Smith, R A Stearns, B A Arison and G T Miwa
      Drug Metabolism and Disposition November 1989, 17 (6) 606-611;

  2. Arison, B A

    1. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
      G L Kedderis, L S Argenbright, J S Walsh, J L Smith, R A Stearns, B A Arison and G T Miwa
      Drug Metabolism and Disposition November 1989, 17 (6) 606-611;

  3. Ashcraft, S B

    1. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
      R H Reuning, S B Ashcraft, J N Wiley and B E Morrison
      Drug Metabolism and Disposition November 1989, 17 (6) 583-589;

  4. Azria, M

    1. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
      M Lemaire, M Azria, R Dannecker, P Marbach, A Schweitzer and G Maurer
      Drug Metabolism and Disposition November 1989, 17 (6) 699-703;

B

  1. Bergstrom, J

    1. Regional differences in adrenal activation of spironolactone: relationship to steroid 17 alpha-hydroxylase activity.
      J H Sherry, P B Johnson, M Levitt, J Bergstrom and H D Colby
      Drug Metabolism and Disposition November 1989, 17 (6) 709-710;

  2. Berk, P D

    1. Dose-related effects of phenobarbital on hepatic glutathione-S-transferase activity and ligandin levels in the rat.
      H Okuda, B J Potter, B Blades, T A McHugh, L N Jacobs and P D Berk
      Drug Metabolism and Disposition November 1989, 17 (6) 677-682;

  3. Black, A

    1. In vivo metabolism of isoxicam in rats, dogs, and monkeys.
      T F Woolf, A Black, J L Hicks, H Lee, C C Huang and T Chang
      Drug Metabolism and Disposition November 1989, 17 (6) 662-668;

  4. Blades, B

    1. Dose-related effects of phenobarbital on hepatic glutathione-S-transferase activity and ligandin levels in the rat.
      H Okuda, B J Potter, B Blades, T A McHugh, L N Jacobs and P D Berk
      Drug Metabolism and Disposition November 1989, 17 (6) 677-682;

  5. Blair, I A

    1. Metabolism of the antianxiety drug buspirone in the rat.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 625-633;
    2. Metabolism of the antianxiety drug buspirone in human subjects.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 634-640;

  6. Boudinot, F D

    1. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
      K J Doshi, J M Gallo, F D Boudinot, R F Schinazi and C K Chu
      Drug Metabolism and Disposition November 1989, 17 (6) 590-594;

  7. Brouwer, K R

    1. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
      K R Brouwer and P J McNamara
      Drug Metabolism and Disposition November 1989, 17 (6) 646-651;
    2. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
      K R Brouwer and P J McNamara
      Drug Metabolism and Disposition November 1989, 17 (6) 652-655;

  8. Buck, W B

    1. Enterohepatic circulation of T-2 toxin metabolites in the rat.
      K A Coddington, S P Swanson, A S Hassan and W B Buck
      Drug Metabolism and Disposition November 1989, 17 (6) 600-605;

  9. Bui, H

    1. The pharmacokinetics of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) in Sprague-Dawley rats.
      M Zorbas, S M Owens, L M Plunkett and H Bui
      Drug Metabolism and Disposition November 1989, 17 (6) 641-645;

  10. Burka, L T

    1. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen.
      M L Cunningham, L T Burka and H B Matthews
      Drug Metabolism and Disposition November 1989, 17 (6) 612-617;

C

  1. Cederbaum, A I

    1. Sensitivity of the rat liver microsomal oxidation of pyrazole to antibody raised against the ethanol-inducible rabbit liver cytochrome P-450 isozyme.
      L A Clejan, D R Koop and A I Cederbaum
      Drug Metabolism and Disposition November 1989, 17 (6) 694-698;

  2. Chang, T

    1. In vivo metabolism of isoxicam in rats, dogs, and monkeys.
      T F Woolf, A Black, J L Hicks, H Lee, C C Huang and T Chang
      Drug Metabolism and Disposition November 1989, 17 (6) 662-668;

  3. Chu, C K

    1. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
      K J Doshi, J M Gallo, F D Boudinot, R F Schinazi and C K Chu
      Drug Metabolism and Disposition November 1989, 17 (6) 590-594;

  4. Clejan, L A

    1. Sensitivity of the rat liver microsomal oxidation of pyrazole to antibody raised against the ethanol-inducible rabbit liver cytochrome P-450 isozyme.
      L A Clejan, D R Koop and A I Cederbaum
      Drug Metabolism and Disposition November 1989, 17 (6) 694-698;

  5. Coddington, K A

    1. Enterohepatic circulation of T-2 toxin metabolites in the rat.
      K A Coddington, S P Swanson, A S Hassan and W B Buck
      Drug Metabolism and Disposition November 1989, 17 (6) 600-605;

  6. Colby, H D

    1. Regional differences in adrenal activation of spironolactone: relationship to steroid 17 alpha-hydroxylase activity.
      J H Sherry, P B Johnson, M Levitt, J Bergstrom and H D Colby
      Drug Metabolism and Disposition November 1989, 17 (6) 709-710;

  7. Cunningham, M L

    1. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen.
      M L Cunningham, L T Burka and H B Matthews
      Drug Metabolism and Disposition November 1989, 17 (6) 612-617;

D

  1. D'Souza, M J

    1. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats.
      S H Pollock, H W Matthews and M J D'Souza
      Drug Metabolism and Disposition November 1989, 17 (6) 595-599;

  2. Dannecker, R

    1. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
      M Lemaire, M Azria, R Dannecker, P Marbach, A Schweitzer and G Maurer
      Drug Metabolism and Disposition November 1989, 17 (6) 699-703;

  3. de Clercq, E

    1. Biotransformation of 5-(2-chloroethyl)-2'-deoxyuridine in male NMRI mice.
      I Szinai and E de Clercq
      Drug Metabolism and Disposition November 1989, 17 (6) 683-689;

  4. Doshi, K J

    1. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
      K J Doshi, J M Gallo, F D Boudinot, R F Schinazi and C K Chu
      Drug Metabolism and Disposition November 1989, 17 (6) 590-594;

  5. du Souich, P

    1. Amiodarone-digoxin interaction in rats. A reduction in hepatic uptake.
      C Lambert, D Lamontagne, H Hottlet and P du Souich
      Drug Metabolism and Disposition November 1989, 17 (6) 704-708;

E

  1. Egger, H

    1. Physiological disposition of CGS 16617 in rat, dog, and man.
      H Egger, G Kochak, P Robertson, R Iannucci, F A Rufino and F Stancato
      Drug Metabolism and Disposition November 1989, 17 (6) 669-672;

  2. Elo, H A

    1. The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro.
      J Mönkkönen, A Urtti, P Paronen, H A Elo and P Ylitalo
      Drug Metabolism and Disposition November 1989, 17 (6) 690-693;

G

  1. Gabriel, S

    1. Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats.
      B D Potts, S Gabriel and C J Parli
      Drug Metabolism and Disposition November 1989, 17 (6) 656-661;

  2. Gallo, J M

    1. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
      K J Doshi, J M Gallo, F D Boudinot, R F Schinazi and C K Chu
      Drug Metabolism and Disposition November 1989, 17 (6) 590-594;

H

  1. Hassan, A S

    1. Enterohepatic circulation of T-2 toxin metabolites in the rat.
      K A Coddington, S P Swanson, A S Hassan and W B Buck
      Drug Metabolism and Disposition November 1989, 17 (6) 600-605;

  2. Hicks, J L

    1. In vivo metabolism of isoxicam in rats, dogs, and monkeys.
      T F Woolf, A Black, J L Hicks, H Lee, C C Huang and T Chang
      Drug Metabolism and Disposition November 1989, 17 (6) 662-668;

  3. Hottlet, H

    1. Amiodarone-digoxin interaction in rats. A reduction in hepatic uptake.
      C Lambert, D Lamontagne, H Hottlet and P du Souich
      Drug Metabolism and Disposition November 1989, 17 (6) 704-708;

  4. Huang, C C

    1. In vivo metabolism of isoxicam in rats, dogs, and monkeys.
      T F Woolf, A Black, J L Hicks, H Lee, C C Huang and T Chang
      Drug Metabolism and Disposition November 1989, 17 (6) 662-668;

I

  1. Iannucci, R

    1. Physiological disposition of CGS 16617 in rat, dog, and man.
      H Egger, G Kochak, P Robertson, R Iannucci, F A Rufino and F Stancato
      Drug Metabolism and Disposition November 1989, 17 (6) 669-672;

J

  1. Jacobs, L N

    1. Dose-related effects of phenobarbital on hepatic glutathione-S-transferase activity and ligandin levels in the rat.
      H Okuda, B J Potter, B Blades, T A McHugh, L N Jacobs and P D Berk
      Drug Metabolism and Disposition November 1989, 17 (6) 677-682;

  2. Jajoo, H K

    1. Metabolism of the antianxiety drug buspirone in the rat.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 625-633;
    2. Metabolism of the antianxiety drug buspirone in human subjects.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 634-640;

  3. Johnson, P B

    1. Regional differences in adrenal activation of spironolactone: relationship to steroid 17 alpha-hydroxylase activity.
      J H Sherry, P B Johnson, M Levitt, J Bergstrom and H D Colby
      Drug Metabolism and Disposition November 1989, 17 (6) 709-710;

K

  1. Kedderis, G L

    1. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
      G L Kedderis, L S Argenbright, J S Walsh, J L Smith, R A Stearns, B A Arison and G T Miwa
      Drug Metabolism and Disposition November 1989, 17 (6) 606-611;

  2. Kochak, G

    1. Physiological disposition of CGS 16617 in rat, dog, and man.
      H Egger, G Kochak, P Robertson, R Iannucci, F A Rufino and F Stancato
      Drug Metabolism and Disposition November 1989, 17 (6) 669-672;

  3. Kochhar, D M

    1. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
      D M Kochhar, J D Penner and L M Minutella
      Drug Metabolism and Disposition November 1989, 17 (6) 618-624;

  4. Koop, D R

    1. Sensitivity of the rat liver microsomal oxidation of pyrazole to antibody raised against the ethanol-inducible rabbit liver cytochrome P-450 isozyme.
      L A Clejan, D R Koop and A I Cederbaum
      Drug Metabolism and Disposition November 1989, 17 (6) 694-698;

L

  1. LaBudde, J A

    1. Metabolism of the antianxiety drug buspirone in the rat.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 625-633;
    2. Metabolism of the antianxiety drug buspirone in human subjects.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 634-640;

  2. Lambert, C

    1. Amiodarone-digoxin interaction in rats. A reduction in hepatic uptake.
      C Lambert, D Lamontagne, H Hottlet and P du Souich
      Drug Metabolism and Disposition November 1989, 17 (6) 704-708;

  3. Lamontagne, D

    1. Amiodarone-digoxin interaction in rats. A reduction in hepatic uptake.
      C Lambert, D Lamontagne, H Hottlet and P du Souich
      Drug Metabolism and Disposition November 1989, 17 (6) 704-708;

  4. Lee, H

    1. In vivo metabolism of isoxicam in rats, dogs, and monkeys.
      T F Woolf, A Black, J L Hicks, H Lee, C C Huang and T Chang
      Drug Metabolism and Disposition November 1989, 17 (6) 662-668;

  5. Lemaire, M

    1. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
      M Lemaire, M Azria, R Dannecker, P Marbach, A Schweitzer and G Maurer
      Drug Metabolism and Disposition November 1989, 17 (6) 699-703;

  6. Levitt, M

    1. Regional differences in adrenal activation of spironolactone: relationship to steroid 17 alpha-hydroxylase activity.
      J H Sherry, P B Johnson, M Levitt, J Bergstrom and H D Colby
      Drug Metabolism and Disposition November 1989, 17 (6) 709-710;

M

  1. Marbach, P

    1. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
      M Lemaire, M Azria, R Dannecker, P Marbach, A Schweitzer and G Maurer
      Drug Metabolism and Disposition November 1989, 17 (6) 699-703;

  2. Matthews, H B

    1. Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen.
      M L Cunningham, L T Burka and H B Matthews
      Drug Metabolism and Disposition November 1989, 17 (6) 612-617;

  3. Matthews, H W

    1. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats.
      S H Pollock, H W Matthews and M J D'Souza
      Drug Metabolism and Disposition November 1989, 17 (6) 595-599;

  4. Maurer, G

    1. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
      M Lemaire, M Azria, R Dannecker, P Marbach, A Schweitzer and G Maurer
      Drug Metabolism and Disposition November 1989, 17 (6) 699-703;

  5. Mayol, R F

    1. Metabolism of the antianxiety drug buspirone in the rat.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 625-633;
    2. Metabolism of the antianxiety drug buspirone in human subjects.
      H K Jajoo, R F Mayol, J A LaBudde and I A Blair
      Drug Metabolism and Disposition November 1989, 17 (6) 634-640;

  6. McHugh, T A

    1. Dose-related effects of phenobarbital on hepatic glutathione-S-transferase activity and ligandin levels in the rat.
      H Okuda, B J Potter, B Blades, T A McHugh, L N Jacobs and P D Berk
      Drug Metabolism and Disposition November 1989, 17 (6) 677-682;

  7. McNamara, P J

    1. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies.
      K R Brouwer and P J McNamara
      Drug Metabolism and Disposition November 1989, 17 (6) 646-651;
    2. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
      K R Brouwer and P J McNamara
      Drug Metabolism and Disposition November 1989, 17 (6) 652-655;

  8. Menargues, A

    1. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
      J Vallès, J Pruñonosa, A Menargues, M Nomen and R Obach
      Drug Metabolism and Disposition November 1989, 17 (6) 673-676;

  9. Minutella, L M

    1. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
      D M Kochhar, J D Penner and L M Minutella
      Drug Metabolism and Disposition November 1989, 17 (6) 618-624;

  10. Miwa, G T

    1. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
      G L Kedderis, L S Argenbright, J S Walsh, J L Smith, R A Stearns, B A Arison and G T Miwa
      Drug Metabolism and Disposition November 1989, 17 (6) 606-611;

  11. Mönkkönen, J

    1. The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro.
      J Mönkkönen, A Urtti, P Paronen, H A Elo and P Ylitalo
      Drug Metabolism and Disposition November 1989, 17 (6) 690-693;

  12. Morrison, B E

    1. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
      R H Reuning, S B Ashcraft, J N Wiley and B E Morrison
      Drug Metabolism and Disposition November 1989, 17 (6) 583-589;

N

  1. Nomen, M

    1. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
      J Vallès, J Pruñonosa, A Menargues, M Nomen and R Obach
      Drug Metabolism and Disposition November 1989, 17 (6) 673-676;

O

  1. Obach, R

    1. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
      J Vallès, J Pruñonosa, A Menargues, M Nomen and R Obach
      Drug Metabolism and Disposition November 1989, 17 (6) 673-676;

  2. Okuda, H

    1. Dose-related effects of phenobarbital on hepatic glutathione-S-transferase activity and ligandin levels in the rat.
      H Okuda, B J Potter, B Blades, T A McHugh, L N Jacobs and P D Berk
      Drug Metabolism and Disposition November 1989, 17 (6) 677-682;

  3. Owens, S M

    1. The pharmacokinetics of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) in Sprague-Dawley rats.
      M Zorbas, S M Owens, L M Plunkett and H Bui
      Drug Metabolism and Disposition November 1989, 17 (6) 641-645;

P

  1. Parli, C J

    1. Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats.
      B D Potts, S Gabriel and C J Parli
      Drug Metabolism and Disposition November 1989, 17 (6) 656-661;

  2. Paronen, P

    1. The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro.
      J Mönkkönen, A Urtti, P Paronen, H A Elo and P Ylitalo
      Drug Metabolism and Disposition November 1989, 17 (6) 690-693;

  3. Penner, J D

    1. Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays.
      D M Kochhar, J D Penner and L M Minutella
      Drug Metabolism and Disposition November 1989, 17 (6) 618-624;

  4. Plunkett, L M

    1. The pharmacokinetics of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) in Sprague-Dawley rats.
      M Zorbas, S M Owens, L M Plunkett and H Bui
      Drug Metabolism and Disposition November 1989, 17 (6) 641-645;

  5. Pollock, S H

    1. Pharmacokinetic analysis of cyclosporine in adjuvant arthritic rats.
      S H Pollock, H W Matthews and M J D'Souza
      Drug Metabolism and Disposition November 1989, 17 (6) 595-599;

  6. Potter, B J

    1. Dose-related effects of phenobarbital on hepatic glutathione-S-transferase activity and ligandin levels in the rat.
      H Okuda, B J Potter, B Blades, T A McHugh, L N Jacobs and P D Berk
      Drug Metabolism and Disposition November 1989, 17 (6) 677-682;

  7. Potts, B D

    1. Metabolism, disposition, and pharmacokinetics of a potent anticonvulsant, 4-amino-N-(2,6-dimethylphenyl)benzamide (LY201116), in rats.
      B D Potts, S Gabriel and C J Parli
      Drug Metabolism and Disposition November 1989, 17 (6) 656-661;

  8. Pruñonosa, J

    1. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
      J Vallès, J Pruñonosa, A Menargues, M Nomen and R Obach
      Drug Metabolism and Disposition November 1989, 17 (6) 673-676;

R

  1. Reuning, R H

    1. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
      R H Reuning, S B Ashcraft, J N Wiley and B E Morrison
      Drug Metabolism and Disposition November 1989, 17 (6) 583-589;

  2. Robertson, P

    1. Physiological disposition of CGS 16617 in rat, dog, and man.
      H Egger, G Kochak, P Robertson, R Iannucci, F A Rufino and F Stancato
      Drug Metabolism and Disposition November 1989, 17 (6) 669-672;

  3. Rufino, F A

    1. Physiological disposition of CGS 16617 in rat, dog, and man.
      H Egger, G Kochak, P Robertson, R Iannucci, F A Rufino and F Stancato
      Drug Metabolism and Disposition November 1989, 17 (6) 669-672;

S

  1. Schinazi, R F

    1. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
      K J Doshi, J M Gallo, F D Boudinot, R F Schinazi and C K Chu
      Drug Metabolism and Disposition November 1989, 17 (6) 590-594;

  2. Schweitzer, A

    1. Disposition of sandostatin, a new synthetic somatostatin analogue, in rats.
      M Lemaire, M Azria, R Dannecker, P Marbach, A Schweitzer and G Maurer
      Drug Metabolism and Disposition November 1989, 17 (6) 699-703;

  3. Sherry, J H

    1. Regional differences in adrenal activation of spironolactone: relationship to steroid 17 alpha-hydroxylase activity.
      J H Sherry, P B Johnson, M Levitt, J Bergstrom and H D Colby
      Drug Metabolism and Disposition November 1989, 17 (6) 709-710;

  4. Smith, J L

    1. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
      G L Kedderis, L S Argenbright, J S Walsh, J L Smith, R A Stearns, B A Arison and G T Miwa
      Drug Metabolism and Disposition November 1989, 17 (6) 606-611;

  5. Stancato, F

    1. Physiological disposition of CGS 16617 in rat, dog, and man.
      H Egger, G Kochak, P Robertson, R Iannucci, F A Rufino and F Stancato
      Drug Metabolism and Disposition November 1989, 17 (6) 669-672;

  6. Stearns, R A

    1. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
      G L Kedderis, L S Argenbright, J S Walsh, J L Smith, R A Stearns, B A Arison and G T Miwa
      Drug Metabolism and Disposition November 1989, 17 (6) 606-611;

  7. Swanson, S P

    1. Enterohepatic circulation of T-2 toxin metabolites in the rat.
      K A Coddington, S P Swanson, A S Hassan and W B Buck
      Drug Metabolism and Disposition November 1989, 17 (6) 600-605;

  8. Szinai, I

    1. Biotransformation of 5-(2-chloroethyl)-2'-deoxyuridine in male NMRI mice.
      I Szinai and E de Clercq
      Drug Metabolism and Disposition November 1989, 17 (6) 683-689;

U

  1. Urtti, A

    1. The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro.
      J Mönkkönen, A Urtti, P Paronen, H A Elo and P Ylitalo
      Drug Metabolism and Disposition November 1989, 17 (6) 690-693;

V

  1. Vallès, J

    1. Oral idazoxan bioavailability in rat. Relevance of intestinal and hepatic first-pass effect.
      J Vallès, J Pruñonosa, A Menargues, M Nomen and R Obach
      Drug Metabolism and Disposition November 1989, 17 (6) 673-676;

W

  1. Walsh, J S

    1. Metabolism of a nitrogen-containing steroid by rat hepatocytes and hepatic subcellular fractions.
      G L Kedderis, L S Argenbright, J S Walsh, J L Smith, R A Stearns, B A Arison and G T Miwa
      Drug Metabolism and Disposition November 1989, 17 (6) 606-611;

  2. Wiley, J N

    1. Disposition and pharmacokinetics of naltrexone after intravenous and oral administration in rhesus monkeys.
      R H Reuning, S B Ashcraft, J N Wiley and B E Morrison
      Drug Metabolism and Disposition November 1989, 17 (6) 583-589;

  3. Woolf, T F

    1. In vivo metabolism of isoxicam in rats, dogs, and monkeys.
      T F Woolf, A Black, J L Hicks, H Lee, C C Huang and T Chang
      Drug Metabolism and Disposition November 1989, 17 (6) 662-668;

Y

  1. Ylitalo, P

    1. The uptake of clodronate (dichloromethylene bisphosphonate) by macrophages in vivo and in vitro.
      J Mönkkönen, A Urtti, P Paronen, H A Elo and P Ylitalo
      Drug Metabolism and Disposition November 1989, 17 (6) 690-693;

Z

  1. Zorbas, M

    1. The pharmacokinetics of [3H]1-[1-(2-thienyl)cyclohexyl]piperidine (TCP) in Sprague-Dawley rats.
      M Zorbas, S M Owens, L M Plunkett and H Bui
      Drug Metabolism and Disposition November 1989, 17 (6) 641-645;
Back to top

In this issue